Clinical Trials Sponsored by Sander van Hootegem

Total 701 results

Sander van Hootegem

Completed

The Diagnostic Value of Staging Laparoscopy and Computed Tomography Response Assessment in Patients With Gastric Adenocarcinoma

Gastric Cancer

Netherlands
Koen van Besien

Withdrawn

Melphalan on Disease Burden Measured by Next Generation Sequencing Before AHCT (Autologous Hematopoietic Cell Transplant) for Multiple Myeloma (AHCT)

Multiple Myeloma

United States
Koen van Besien

Completed

Vactosertib in Combination w/ Pomalidomide in Relapsed or Relapsed and Refractory Multiple Myeloma

Multiple Myeloma

United States
Elizabeth Van Eycken
Flemish League Against Cancer

Completed

Quality of Life in Colorectal (ex-)Cancer Patients, Based on the Belgian Cancer Registry. (QOLColorect)

Quality of Life | Colorectal Cancer

Belgium
The Netherlands Cancer Institute
Maarten van de Weijden Foundation

Recruiting

COntinue the SaMe Systemic Therapy After Local Ablative Therapy for Oligo Progression in Metastatic Breast Cancer - the COSMO Study (COSMO)

Oligoprogressive | Metastatic Cancer | Breast Cancer Invasive

Netherlands
Fox Chase Cancer Center
Stand Up To Cancer; Van Andel Research Institute

Active, not recruiting

Atezolizumab + Guadecitabine in Patients With Checkpoint Inhibitor Refractory or Resistant Urothelial Carcinoma

Urothelial Carcinoma

United States
San Antonio Cancer Institute

Completed

BMS-184476 in Treating Patients With Advanced Solid Tumors

Unspecified Adult Solid Tumor, Protocol Specific

United States
San Antonio Cancer Institute

Completed

Combination Chemotherapy in Treating Patients With Metastatic Solid Tumors

Unspecified Adult Solid Tumor, Protocol Specific

United States
Fan Yun, MD

Completed

Apatinib for Extensive Stage Small Cell Lung Cancer After Second/Third Line Chemotherapy.

Small Cell Lung Cancer

China
Tim Van den Wyngaert
Kom Op Tegen Kanker

Recruiting

Best Treatment Choice for Osteonecrosis of the Jaw (BETCON)

Medication Related Osteonecrosis of the Jaw

Belgium
Academisch Medisch Centrum - Universiteit van Amsterdam...
Dutch Cancer Society

Recruiting

Evidence Based Information Provision to Improve Decision Making After Oesophagogastric Cancer Diagnosis (SOURCE) (SOURCE)

Gastric Cancer | Oesophageal Cancer

Netherlands
Academisch Medisch Centrum - Universiteit van Amsterdam...
Dutch Cancer Society

Unknown

Pediatric Research on Improving Speed, Memory and Attention (PRISMA)

Brain Tumors

Netherlands
Daniëlle van de Graaf
Comprehensive Cancer Centre The Netherlands; Dutch Cancer Society

Recruiting

Effectiveness of Online ACT for Pain Interference in Cancer Survivors With Chronic Painful CIPN (QLIPP-CIPN)

Chemotherapy-induced Peripheral Neuropathy | Cancer Survivors

Netherlands
Lonneke van de Poll-Franse
Comprehensive Cancer Centre The Netherlands; Dutch Cancer Society

Completed

ROGYcare: The Impact of a Cancer Survivorship Care Plan on Patient Reported Outcomes and Health Care Providers (ROGYcare)

Ovarian Cancer | Endometrium Cancer

Netherlands
The Netherlands Cancer Institute
Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)

Not yet recruiting

Galunisertib Combined With Capecitabine in Advanced CRC With PM

Colorectal Cancer Metastatic | Peritoneal Carcinomatosis

Netherlands
University of Southern California
National Cancer Institute (NCI); Van Andel Research Institute

Active, not recruiting

Guadecitabine and Durvalumab in Treating Patients With Advanced Liver, Pancreatic, Bile Duct, or Gallbladder Cancer

Unresectable Pancreatic Carcinoma | Metastatic Pancreatic Adenocarcinoma | Recurrent Pancreatic Carcinoma | Stage III Pancreatic Cancer AJCC v6 and v7 | Stage IV Pancreatic Cancer AJCC v6 and v7 | Recurrent Gallbladder Carcinoma | Unresectable Gallbladder Carcinoma | Recurrent Hepatocellular Carcinoma and other conditions

United States
Sidney Kimmel Comprehensive Cancer Center at Johns...
Van Andel Research Institute

Withdrawn

Study of Mitomycin-C in Patients With Advanced or Recurrent Pancreatic Cancer With Mutated BRCA2 Gene

Pancreatic Cancer

United States
Academisch Medisch Centrum - Universiteit van Amsterdam...

Unknown

J-Pouch Coloanal Anastomosis Compared With Side-to-End Coloanal Anastomosis After Radiation Therapy and Surgery to Remove the Rectum in Treating Patients With Rectal Adenocarcinoma

Colorectal Cancer | Perioperative/Postoperative Complications

Netherlands
Academisch Medisch Centrum - Universiteit van Amsterdam...

Unknown

Cisplatin Combined With Radiation Therapy and Hyperthermia in Treating Patients With Stage II, Stage III, or Stage IV Cervical Cancer

Cervical Cancer

Netherlands
Institut du Cancer de Montpellier - Val d'Aurelle

Not yet recruiting

Prevention of Postoperative Complications by Negative Pressure Therapy After Complex Breast Cancer Surgery (TPN-SEIN)

Breast Cancer

France
Wu Nan

Not yet recruiting

A Multicenter Prospective Study to Assess the Effects of Adjuvant Icotinib in EGFRm Stage I NSCLC With High-risk of Disease Recurrence After Complete Resection

Non-Small Cell Lung Cancer
Institut du Cancer de Montpellier - Val d'Aurelle

Recruiting

Assessment of Cardiac Coherence Associated With Medical Hypnosis on Preoperative Anxiety in Oncological Surgery (COHEC2)

Surgery | Oncology

France
Institut du Cancer de Montpellier - Val d'Aurelle

Recruiting

Study Evaluating the Tailored Management of Locally-advanced Rectal Carcinoma (GRECCAR14)

Rectal Carcinoma | Locally Advanced Malignant Neoplasm

France
Institut du Cancer de Montpellier - Val d'Aurelle

Recruiting

Creation of a Clinical Database on Primary Nervous System Tumors (BDD-NO)

Nervous System Tumor

France
Institut du Cancer de Montpellier - Val d'Aurelle

Recruiting

Predictive Toxicity Test Linked to Radiotherapy After Mastectomy and Immediate Implant Reconstruction (PRETORIA)

Breast Cancer | Capsular Contracture Associated With Breast Implant

France
Institut du Cancer de Montpellier - Val d'Aurelle

Recruiting

Predictive Value of microRNA in Thyroid Cytologies of Undetermined Type (PREDICYTHY)

Thyroid Cancer

France
Institut du Cancer de Montpellier - Val d'Aurelle

Recruiting

Identification of a New Blood Biomarker for the Diagnosis and Prognosis of Liposarcomas (ESPACE)

Liposarcoma | Atypical Lipomatous Tumor

France
Institut du Cancer de Montpellier - Val d'Aurelle

Recruiting

Liquid Biopsies and IMAging for Improved Cancer Care (LIMA)

Rectal Cancer

France
Institut du Cancer de Montpellier - Val d'Aurelle

Recruiting

Prospective Monocentric Clinical-biological Database (BCBPancréas)

Pancreatic Cancer

France
Institut du Cancer de Montpellier - Val d'Aurelle

Recruiting

Mouth Opening, Prevention, Education, Nutrition (OPEN) (OPEN)

Head and Neck Cancer | Trismus

France
Institut du Cancer de Montpellier - Val d'Aurelle

Recruiting

A Clinicobiological Database in Metastatic Digestive Cancers (BCB-CBIO-DIG)

Digestive System Neoplasm

France
Institut du Cancer de Montpellier - Val d'Aurelle

Recruiting

Treatment of Malignant Peritoneal Mesothelioma (MESOTIP) (MESOTIP)

Peritoneal Carcinomatosis | Peritoneal Mesothelioma

France
Institut du Cancer de Montpellier - Val d'Aurelle

Completed

Sphincter-preserving Surgery After Preoperative Treatment of Ultra-low Rectal Carcinoma (GRECCAR1)

Rectal Cancer

France
Institut du Cancer de Montpellier - Val d'Aurelle

Active, not recruiting

Evaluation of Late Toxicity Following Intensity-Modulated Radiotherapy and Two Image-Guided Strategies With Corresponding Treatment Margins. (RCMIGI)

Prostate Cancer

France
Institut du Cancer de Montpellier - Val d'Aurelle

Completed

Feasibility Study: Yoga Educational Project (SKYPE)

Breast Cancer

France
Institut du Cancer de Montpellier - Val d'Aurelle

Active, not recruiting

Efficacy of an Oral Immunomodulatory Nutrient on Survival During Postoperative Concomitant Chemoradiotherapy in Head and Neck Cancer (SIMPA01)

Head and Neck Squamous Cell Carcinoma

France
Institut du Cancer de Montpellier - Val d'Aurelle

Completed

Cetuximab and Combination Chemotherapy as First-Line Therapy in Treating Patients With Metastatic Colorectal Cancer

Colorectal Cancer

France
Institut du Cancer de Montpellier - Val d'Aurelle

Completed

First Line Treatment of Patients With Metastatic Pancreatic Adenocarcinoma. (GABRINOX)

Metastatic Pancreatic Adenocarcinoma

France
Institut du Cancer de Montpellier - Val d'Aurelle

Unknown

Predictive Role of New Biomarkers for Hypersensitive Patients to Radiation in Breast Cancer (BIORISE) (BIORISE)

Breast Cancer

France
Institut du Cancer de Montpellier - Val d'Aurelle

Completed

Hypnosis for Patients Treated With Adjuvant Chemotherapy for Breast Cancer(HYPNOVAL) (HYPNOVAL)

Breast Cancer

France
Institut du Cancer de Montpellier - Val d'Aurelle

Completed

Activity of Regorafenib in Combination With Chemotherapy in Patients With Advanced Biliary Tract Cancer (BREGO)

Digestive Cancer

France
Institut du Cancer de Montpellier - Val d'Aurelle

Completed

A Trial Assessing Several Schedules of Oral S-1 in Combination With a Fixed Dose of Oxaliplatin and Irinotecan (SIRINOX)

Digestive Cancer

France
Institut du Cancer de Montpellier - Val d'Aurelle

Completed

Sorafenib in Combination With Irinotecan in Metastatic Colorectal Cancer Patients With KRAS Mutated Tumors (NEXIRI2)

Metastatic Colorectal Cancer Patients With KRAS Mutated Tumors

France
Institut du Cancer de Montpellier - Val d'Aurelle

Completed

Cetuximab and Trastuzumab in Treating Patients With Metastatic Pancreatic Cancer That Progressed After Previous Treatment With Gemcitabine (THERAPY)

Pancreatic Cancer

France
Institut du Cancer de Montpellier - Val d'Aurelle

Terminated

A Trial Evaluating Concurrent Whole Brain Radiotherapy and Iniparib in Multiple Non Operable Brain Metastases (RAPIBE)

Brain Metastases

France
Institut du Cancer de Montpellier - Val d'Aurelle

Completed

Trial Evaluating Combined Chemotherapy in Patients With Metastatic Pancreatic Adenocarcinoma (GATE 1)

Metastatic Pancreatic Adenocarcinoma

France
Institut du Cancer de Montpellier - Val d'Aurelle

Completed

Patients With Brain Metastases From HER2-positive Breast Cancer (BIRTH)

HER2-positive Breast Cancer

France
Institut du Cancer de Montpellier - Val d'Aurelle

Completed

Safety and Efficacity of NFL101 as Tobacco Therapy (CESTO)

Smoking

France
Institut du Cancer de Montpellier - Val d'Aurelle

Completed

Everolimus, Bicalutamide, and Leuprolide Acetate in Treating Patients Undergoing Radiation Therapy For High-Risk Locally Advanced Prostate Cancer

Prostate Cancer

France
Institut du Cancer de Montpellier - Val d'Aurelle

Not yet recruiting

Personalization of Breast Radiotherapy According to Loco-regional Recurrence Risk and Toxicity Probability (PROBA)

Breast Cancer

France

Clinical Trials Sponsored by Sander van Hootegem

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Hong Kong

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations